November 2016

Leaders of three congressional committees have raised concerns about how the Centers for Medicare and Medicaid Services…

Handling whistleblowers is one of the biggest challenges facing most compliance officers. Furthermore, recent actions taken by the…

After almost fifteen months of campaigning, polls, and 24/7 election coverage of “he-said-she-said,” we finally have our answer:…

The United States Health and Human Services (HHS) Office of Inspector General (OIG) recently released its 2017 Work Plan, which…

There are some strong indicators to suggest that 2016 is on track to be a real banner year regarding Foreign Corrupt Practices Act…

We recently wrote about Proposition 61 in California – a measure that would have required drug makers to provide large discounts…

GlaxoSmithKline (“GSK”) reached a settlement with the Chinese government in 2014 related to bribes and improper actions taken by…

Yesterday, the Food and Drug Administration (FDA) kicked off a two-day public meeting to review the extent to which off-label…

A 2015 study is coming back to the forefront with a new interview by Dr. Anupam Jena. Dr. Jena authored the 2015 study, Physician…

Medicaid Fraud Control Units play an important, if often overlooked, role in the Government’s continuing effort to control…